课题基金 / 基金详情

Study on Structure and Function of Vero Toxins (Shiga-like) Toxins Produced by EscherichiaDB coli

Study on Structure and Function of Vero Toxins (Shiga-like) Toxins Produced by EscherichiaDB coli
大肠杆菌产生的Vero毒素(类志贺毒素)的结构与功能研究
批准号:
01480174
负责人:
TAKEDA Yoshifumi
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990

项目摘要

项目成果

TAKEDA Yoshifumi的其他基金

相似基金

相关文献

中文摘要
翻译
肠出血性大肠埃希菌可引起婴儿腹泻、出血性结肠炎和溶血性尿毒症综合征。发病机制被认为与生物体产生的Vero毒素密切相关。据报道,两种Vero毒素(VT1和VT2)都具有RNA N-糖苷酶活性,并从真核细胞60S核糖体亚基的28S核糖体RNA的N端断裂4324位的腺苷糖苷键。这种酶活性导致抑制EF-u依赖的tRNA结合,从而抑制蛋白质合成。对VT1、VT2的A亚基和蓖麻毒素A链的一级结构进行了比较,发现了三个保守的区域(来自VT1 N端的氨基酸残基51-55、167-171和202-207)。X-射线晶体衍射分析表明,蓖麻毒素A链上的三个区域在位置上都与蓖麻毒素的活性中心相对应。为了确定保守氨基酸残基对VT1毒素活性的相对重要性,我们通过寡核苷酸定向定点突变的方法制备了单一氨基酸取代的VT1突变体。制备了22个突变体,检测了14个保守残基,并比较了它们对Vero细胞的细胞毒性和对兔网织红细胞裂解物中蛋白质合成的抑制活性。将167位的谷氨酸替换为谷氨酰胺,将170位的精氨酸替换为亮氨酸,这两种活性都大大降低。这些结果表明,谷氨酸在167位和精氨酸在170位在VT1的毒素活性中起重要作用。这些突变毒素作为保护性抗原(S)保护肠出血性大肠杆菌感染的可能性有待进一步研究。
英文摘要
Enterohemorrhagic Escherichia coli causes infant diarrhea, hemorrhagic colitis and hemolytic uremic syndrome in man. Pathogenesis is considered to be closely related to Vero toxins produced by the organisms. It has been reported that both two types of Vero toxins (VT1 and VT2) show RNA N-glycosidase activity and cleave a glycosidic bond of adenosine at position 4324 from N-terminus of 28S ribosomal RNA of 60S ribosomal subunit of eukaryotic cells. This enzymatic activity results in the inhibition of EF-u dependent tRNA binding and thus the inhibition of protein synthesis. This mode of action to that of ricin.Comparison of the primary structures of the A subunits of VT1, VT2 and the ricin A chain revealed three conserved regions (amino acid residues 51-55, 167-171 and 202-207 from the N-terminus of VT1). All three regions of the ricin A chain corresponded in position to the active site of ricin proposed by X-ray crystal diffraction analysis. To determine the relative importance of the conserved amino acid residues for toxin activity of VT1, we prepared VT1 mutants with single amino-acid substitutions by oligonucleotide-directed site-specific mutagenesis. Twenty-two mutants were prepared to examine 14 conserved residues and their cytotoxicities to Vero cells and inhibitory activities on protein synthesis in a rabbit reticulocyte lysate were compared with those of wild-type VT1. Replacement of glutamic acid at position 167 by glutamine and of arginine at position 170 by leucine reduced both activities drastically. These results suggest that glutamic acid at position 167 and arginine at position 170 play the important role in the toxin activity of VT1. A possibility of these mutant toxins to be protective antigen (s) to protect enterohemorrhagic E. Coli infection wil be further studied.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
Hedeaki Ito et al.: "Cloninq and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli 091:H21 isolated from a patient with the hemolytic uremic syndrome." Microbial pathogenesis.
Hedeaki Ito 等人:“对从溶血性尿毒症综合征患者体内分离出的大肠杆菌 091:H21 进行 Vero 毒素 2 变异基因的克隆和核苷酸测序。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuichi Oku: "Purification and some properties of a Vero toxin from a human strain of OOEscherichiaWWーPP OOcoliWWーPP that is immunologically related to Shigaーlike toxin II(VT2)." Microbial Pathogenesis. 6. 113-122 (1989)
Yuichi Oku:“来自 OOEscherichiaWW-PP OOcoliWW-PP 人类菌株的 Vero 毒素的纯化和一些特性,该毒素与志贺样毒素 II (VT2) 具有免疫相关性。” 6. 113-122 (1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masayuki Furutani: "Demonstration of RNA Nーglycosidase activity of a Vero toxin(VT2 variant)produced by OOEscherichiaWWーPP OOcoliWWーPP O91:H21 from a patient with the hemolytic uremic syndrome." Microbiology Immunology. 34. 387-392 (1990)
Masayuki Furutani:“溶血性尿毒症综合征患者产生的 Vero 毒素(VT2 变体)的 RNA N-糖苷酶活性的演示 34. 387-392(1990 年)。 )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masayuki Furutani et al.: "Demonstration of RNA N-glycosidase activity of a Vero toxin(VT2 variant)produced by Escherichia coli 091:H21 from a patient with the hemolytic uremic syndome." Microbial pathogenesis.
Masayuki Furutani 等人:“证实溶血性尿毒症综合征患者的大肠杆菌 091:H21 产生的 Vero 毒素(VT2 变体)的 RNA N-糖苷酶活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Development of a vaccine against enterohemorrhagic Escherichia coli
    Mechanism of development of diarrhea by enteric bacteria
    Development of Vaccine againest New Serotype O139 Bengal of Vibrio cholerae
    • 批准号:
      07044302
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $3.33万
    • 财政年份:
      1995
    • 负责人:
      TAKEDA Yoshifumi
    • 依托单位:
    Deparment of vaccine for new type of Vibrio cholerae O139 Bengal
    海外基金